Copyright
©The Author(s) 2004.
World J Gastroenterol. Apr 1, 2004; 10(7): 954-958
Published online Apr 1, 2004. doi: 10.3748/wjg.v10.i7.954
Published online Apr 1, 2004. doi: 10.3748/wjg.v10.i7.954
Table 1 Growth inhibition of SMMC-7721 cells by HMBA
Concentrition(mmol/L) | 24h treatment | 48h treatment | 72h treatment | |||
A570 | I R (%) | A570 | I R (%) | A570 | I R (%) | |
0 | 0.201 ± 0.029 | / | 0.409 ± 0.064 | / | 0.788 ± 0.037 | / |
5.0 | 0.155 ± 0.009 | 22.9 | 0.238 ± 0.031 | 47.2 | 0.385 ± 0.033 | 51.1 |
7.5 | 0.154 ± 0.011 | 23.4 | 0.216 ± 0.046 | 47.2 | 0.295 ± 0.031 | 62.6 |
10.0 | 0.146 ± 0.013 | 27.4 | 0.209 ± 0.020 | 48.9 | 0.247 ± 0.019 | 68.7 |
12.5 | 0.133 ± 0.021 | 33.8 | 0.195 ± 0.024 | 52.3 | 0.206 ± 0.021 | 73.9 |
- Citation: Ouyang GL, Cai QF, Liu M, Chen RC, Huang Z, Jiang RS, Chen F, Hong SG, Bao SD. Growth arrest and apoptosis of human hepatocellular carcinoma cells induced by hexamethylene bisacetamide. World J Gastroenterol 2004; 10(7): 954-958
- URL: https://www.wjgnet.com/1007-9327/full/v10/i7/954.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i7.954